Histological classification of Japanese IgA nephropathy with a small number of glomeruli using Bayes' theorem.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
31 10 2023
Historique:
received: 15 08 2023
accepted: 23 10 2023
medline: 2 11 2023
pubmed: 1 11 2023
entrez: 1 11 2023
Statut: epublish

Résumé

In Japan an original pathological classification of IgA nephropathy was used, while Oxford classification of IgA nephropathy was used globally. The Oxford classification requires ≥ 8 glomeruli while the Japanese classification requires ≥ 10. Ninety-nine patients diagnosed with IgA nephropathy were included. To determine the accuracy of histological staging, we calculated the posterior probability using Bayes' theorem and adopted three model of prior distribution. First, the actual staging distribution was reclassified using the beta distribution (reclassified distribution). Second a model with the same distribution (actual distribution) as the actual staging was used. Third, a model assuming that all cases are equally distributed (equal distribution) was used. The median number of collected glomeruli was 12 (8-19). There were 33 cases (33%) wherein the glomerular count was ≤ 9. When only cases with ≥ 10 glomeruli were included, the median posterior probability was 91% (74-99) (actual distribution, 90% [74-98]; equal distribution, 85% [73-96]). Even among the 33 cases with ≤ 9 glomeruli, there were approximately 7 cases in which the posterior probability was ≥ 90% for each model. Using Bayesian probabilistic analysis, it was possible to evaluate the histologic classification of IgA nephropathy, even when the number of obtained glomeruli was ≤ 9.

Identifiants

pubmed: 37907505
doi: 10.1038/s41598-023-45734-8
pii: 10.1038/s41598-023-45734-8
pmc: PMC10618293
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18663

Informations de copyright

© 2023. The Author(s).

Références

Kidney Int. 2009 Sep;76(5):546-56
pubmed: 19571790
Am J Med. 1990 Aug;89(2):209-15
pubmed: 2200265
Clin Exp Nephrol. 2017 Dec;21(6):986-994
pubmed: 28349230
Semin Nephrol. 2018 Sep;38(5):435-442
pubmed: 30177015
Clin Exp Nephrol. 2015 Dec;19(6):1135-41
pubmed: 25951807
Clin Exp Nephrol. 2008 Aug;12(4):250-255
pubmed: 18286351
Clin Exp Nephrol. 2019 Jan;23(1):16-25
pubmed: 30367317
Stat Med. 2002 Sep 30;21(18):2653-69
pubmed: 12228883
Clin Exp Nephrol. 2016 Aug;20(4):511-535
pubmed: 27095365
Clin Exp Nephrol. 2021 Jan;25(1):19-27
pubmed: 32880761
Nephrol Dial Transplant. 2012 Jan;27(1):252-8
pubmed: 21606384
Am J Kidney Dis. 1988 Nov;12(5):340-7
pubmed: 3055955
Semin Nephrol. 2018 Sep;38(5):477-484
pubmed: 30177019
Stat Med. 2005 Apr 30;24(8):1203-17
pubmed: 15558709
Clin Exp Nephrol. 2016 Feb;20(1):94-102
pubmed: 26123429
J Nephrol. 2013 Mar-Apr;26(2):350-7
pubmed: 22684645
Am J Kidney Dis. 2013 Nov;62(5):891-9
pubmed: 23820066
Clin Exp Nephrol. 2016 Aug;20(4):618-627
pubmed: 26577676
Biometrics. 2004 Jun;60(2):388-97
pubmed: 15180664
Am J Kidney Dis. 1997 Jun;29(6):829-42
pubmed: 9186068
Kidney Int. 2009 Sep;76(5):534-45
pubmed: 19571791

Auteurs

Takeshi Nakata (T)

Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu city, Oita, 879-5593, Japan. takeshi.nakata@gmail.com.

Masato Tanigawa (M)

Department of Biophysics, Faculty of Medicine, Oita University, Yufu-City, Japan.

Akihiro Fukuda (A)

Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu city, Oita, 879-5593, Japan.

Hirotaka Shibata (H)

Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu city, Oita, 879-5593, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH